Intestinal permeability before and after ibuprofen in families of children with Crohn's disease

Canadian Journal of Gastroenterology

Volumn 13, Issue 1, 1999, Pages 31-36

  Zamora, Samuel A ^a   Hilsden, Robert J ^b   Meddings, Jon B ^a   Butzner, J Decker ^a   Scott, R Brent ^a   Sutherland, Lloyd R ^b  

^a 3330 Hospital Dr NW   (Canada)

^b Health Sciences Centre Calgary   (Canada)

Author keywords

Crohn's disease; Inflammatory bowel disease; Intestinal permeability; Nonsteroidal anti inflammatory drugs (NSAIDs)

Indexed keywords

IBUPROFEN; LACTULOSE; MANNITOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENETIC ASSOCIATION; HUMAN; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE VALUE; RELATIVE; SIBLING;

EID: 0032927620     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1999/457315     Document Type: Article

References (39)

1. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen IA, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med 1991;324:84-8.
2. Fielding JF. The relative risk of inflammatory bowel disease among parents and siblings of Crohn's disease patients. J Clin Gastroenterol 1986;8:655-7.
3. Lashner BA, Evans AA, Kirsner JB, Hanauer SB. Prevalence and incidence of inflammatory bowel disease in family members. Gastroenterology 1986;91:1396-400.
4. Mayberry JF, Rhodes J, Newcombe RG. Familial prevalence of inflammatory bowel disease in relatives of patients with Crohn's disease. Br Med J 1980;280:84.
5. Weterman IT, Pena AS. Familial incidence of Crohn's disease in The Netherlands and a review of the literature. Gastroenterology 1984;86:449-52.
6. Yang H, McElree C, Roth M-P, Shanahan F, Targan SR, Rotter JI. Familial empirical risks for inflammatory bowel disease: Differences between Jews and non-Jews. Gut 1993;34:517-24.
7. Hollander D, Vadheim CM, Brettholz E, Petersen GM, Delahunty T, Rotter JI. Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 1986;105:883-5.
8. 51Cr-labelled ethylenediaminetetraacetic acid in patients with Crohn's disease and their healthy relatives. Scand J Gastroenterol 1989;24:993-8.
9. Howden CW, Gillanders I, Morris AJ, Duncan A, Daneh B, Russell RI. Intestinal permeability in patients with Crohn's disease and their first-degree relatives. Am J Gastroenterol 1994;89:1175-6.
10. Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology 1989;97:927-31.
11. Munkholm P, Langholz E, Hollander D, et al. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives. Gut 1994;35:68-72.
12. Ruttenberg D, Young GO, Wright JP, Isaacs S. Peg-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers. Dig Dis Sci 1992;37:705-8.
13. Teahon K, Smethurst P, Levi AJ, Menzies IS, Bjarnason I. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 1992;33:320-3.
14. Valpiani D, Ornigotti L, Rossellini SR. Intestinal permeability in patients with Crohn's disease and first grade relatives. Gastroenterology 1992;102:A708. (Abst)
15. Lindberg E, Soderholm JD, Olaison G, Jarnerot G. Intestinal permeability to polyethylene glycols in monozygotic twins with Crohn's disease. Scand J Gastroenterol 1995;30:780-3.
16. May GR, Sutherland LR, Meddings JB. Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 1993;104:1627-32.
17. Pironi L, Miglioli M, Ruggeri E, et al Effect of non-steroidal anti-inflammatory drugs (NSAID) on intestinal permeability of first degree relatives of patients with Crohn's disease. Gastroenterology 1992;102:A679. (Abst)
18. Hilsden RJ, Meddings JB, Sutherland LR. Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. Gastroenterology 1996;110:1395-403.
19. Singer HC, Anderson JG, Frischer H, Kirsner JB. Familial aspects of inflammatory bowel disease. Gastroenterology 1971;61:423-30.
20. Polito JM, Rees RC, Childs B, Mendeloff AI, Harris ML, Bayless TM. Preliminary evidence for genetic anticipation in Crohn's disease. Lancet 1996;347:798-800.
21. Colombel JF, Grandbastien B, Gower-rousseau C, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 1996;111:604-7.
22. Polito JM II, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: Influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996;111:580-6.
23. Satsangi J, Grootscholten C, Holt H, Jewell DP. Clinical patterns of familial inflammatory bowel disease. Gut 1996;38:738-41.
24. Griffiths A, Harris K, Smith C, et al. Is there "anticipation" in familial Crohn's disease? Gastroenterology 1997;112:A985. (Abst)
25. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
26. Kuster W, Pascoe L, Purrmann J, Funk S, Majewski F. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet 1989;32:105-8.
27. Orholm M, Iselius L, Sorensen TI, Munkholm P, Langholz E, Binder V. Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. Br Med J 1993;306:20-4.
28. Bjarnason I, O'Morain C, Levi AJ, Peters TJ. Absorption of 51-Chromium-labeled ethylendiaminetetraacetate in inflammatory bowel disease. Gastroenterology 1983;85:18-22.
29. Ukabam SO, Clamp JR, Cooper BT. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 1983;27:70-4.
30. Olaison G, Leandersson P, Sjodahl R, Tagesson C. Intestinal permeability to polyethylene glycol 600 in Crohn's disease. Preoperative determination in a defined segment of small intestine. Gut 1988;29:196-9.
31. Issenman RM, Jenkins RT, Radoja C. Intestinal permeability compared in pediatric patients and adults patients with inflammatory bowel disease. Clin Invest Med 1993;16:187-96.
32. Murphy MS, Eastham EJ, Nelson R, Pearson AD, Laker MF. Intestinal permeability in Crohn's disease. Arch Dis Child 1989;64:321-5.
33. Turck D, Ythier H, Maquet E, et al. Intestinal permeability to [51Cr]EDTA in children with Crohn's disease and celiac disease. J Pediatr Gastroenterol Nutr 1987;6:535-7.
34. Van Elburg RM, Uil JJ, Kokke FTM, et al. Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. J Pediatr Gastroenterol Nutr 1995;20:184-8.
35. Prytz H, Benoni C, Tagesson C. Does smoking tighten the gut? Scand J Gastroenterol 1989;24:1084-8.
36. Den Hond E, Peeters M, Ghoos Y, et al. The increase of intestinal permeability caused by oral indomethacin is reduced by smoking. Gastroenterology 1997;112:A957. (Abst)
37. Soderholm J, Olaison G, Sjodahl R, Tagesson C. Smoking and intestinal absorption of oral polyethylene glycols in Crohn's disease. Scand J Gastroenterol 1993;28:163-7.
38. Cope GF, Goode HF, Heatley RV, Kelleher J. Measurement of intestinal permeability by high pressure chromatography, the effect of cigarette smoking. Clin Sci 1988;75(Suppl 19):8. (Abst)
39. Zamora SA, Scott RB, Butzner DJ, Hilsden RJ, Meddings J, Sutherland LR. Intestinal permeability before and after ibuprofen in families of children with Crohn's disease. Gastroenterology 1997;112:A1127. (Abst)